PROF (Profound Medical) Cyclically Adjusted Book per Share: $2.52 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PROF Profound Medical Corp PROF
74 GF Score
Price $6.79
GF Value $10.77
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Profound Medical Cyclically Adjusted Book per Share?

Profound Medical PROF +2.03% 74 Cyclically Adjusted Book per Share is $2.52 as of Jun. 2026. GuruFocus rates PROF with a GF Score™ of 74/100 and a GF Value™ of $10.77 (Possible Value Trap). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Profound Medical's adjusted book value per share for the three months ended in Jun. 2026 was $1.363. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.52 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Profound Medical's average Cyclically Adjusted Book Growth Rate was -2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-21), Profound Medical's current stock price is $6.79. Profound Medical's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $2.52. Profound Medical's Cyclically Adjusted PB Ratio of today is 2.69.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Profound Medical was 3.63. The lowest was 1.52. And the median was 2.57.


Profound Medical  (NAS:PROF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Profound Medical's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=6.79/2.52
=2.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Profound Medical was 3.63. The lowest was 1.52. And the median was 2.57.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Profound Medical Cyclically Adjusted Book per Share Related Terms


Profound Medical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Profound Medical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical Cyclically Adjusted Book per Share Chart

Profound Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2.68 2.57

Profound Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.67 2.57 2.57 2.58 2.52

PROF vs ABT, SYK, MDT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Profound Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Profound Medical's Cyclically Adjusted PB Ratio falls into.


PROF
74GF Score
Profound Medical Corp PROF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profound Medical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Profound Medical's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.363/133.5265*133.5265
=1.363

Current CPI (Jun. 2026) = 133.5265.

Profound Medical Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.562 101.765 0.737
201612 1.996 101.449 2.627
201703 1.467 102.634 1.909
201706 0.919 103.029 1.191
201709 2.026 103.345 2.618
201712 1.538 103.345 1.987
201803 2.995 105.004 3.809
201806 2.534 105.557 3.205
201809 2.229 105.636 2.818
201812 1.809 105.399 2.292
201903 1.656 106.979 2.067
201906 1.298 107.690 1.609
201909 1.485 107.611 1.843
201912 1.212 107.769 1.502
202003 3.297 107.927 4.079
202006 3.153 108.401 3.884
202009 4.740 108.164 5.851
202012 4.817 108.559 5.925
202103 4.594 110.298 5.562
202106 4.410 111.720 5.271
202109 4.238 112.905 5.012
202112 3.880 113.774 4.554
202203 3.583 117.646 4.067
202206 3.256 120.806 3.599
202209 2.880 120.648 3.187
202212 2.491 120.964 2.750
202303 2.308 122.702 2.512
202306 2.087 124.203 2.244
202309 1.805 125.230 1.925
202312 1.461 125.072 1.560
202403 1.877 126.258 1.985
202406 1.603 127.522 1.678
202409 1.260 127.285 1.322
202412 2.011 127.364 2.108
202503 1.690 129.181 1.747
202506 1.306 129.892 1.343
202509 1.065 130.287 1.091
202512 1.830 130.366 1.874
202603 1.635 132.262 1.651
202606 1.363 133.527 1.363

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $2.52 mean?
Profound Medical (PROF) has a Cyclically Adjusted Book per Share of $2.52 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Profound Medical and its competitors.
Is Profound Medical's Cyclically Adjusted Book per Share too high?
Profound Medical's current Cyclically Adjusted Book per Share is $2.52. Overall, Profound Medical has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Profound Medical's Cyclically Adjusted Book per Share compare to ABT and SYK?
Profound Medical's Cyclically Adjusted Book per Share of $2.52 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Profound Medical and its competitors. Profound Medical's current Cyclically Adjusted Book per Share is $2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profound Medical stock overvalued right now?
Based on GuruFocus' analysis, Profound Medical (PROF) is currently considered Possible Value Trap. The stock's GF Value™ is $10.77, compared to a current price of $6.79 — trading 37% below its estimated fair value. The current Cyclically Adjusted Book per Share is $2.52. Profound Medical's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Profound Medical (PROF), the current Cyclically Adjusted Book per Share is $2.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Profound Medical (PROF) Overvalued in 2026?

Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued. The current stock price of $6.79 is trading 37% below its estimated GF Value™ of $10.77. GuruFocus considers Profound Medical to be Possible Value Trap.

Key valuation signals for PROF:

  • Cyclically Adjusted Book per Share: $2.52
  • GF Value™: $10.77 vs. price of $6.79 (37% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the PROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Profound Medical Business Description

Other Exchanges PRN:Canada
Address 2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
74GF Score

Get the complete analysis for PROF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.79
Price
$10.77
GF Value